The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma
- 5 June 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 43 (7), 668-672
- https://doi.org/10.1038/ng.855
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Frequent Mutation of BAP1 in Metastasizing Uveal MelanomasScience, 2010
- Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemiaBlood, 2010
- Defining the Human Deubiquitinating Enzyme Interaction LandscapeCell, 2009
- Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia PhenotypeDevelopmental Cell, 2009
- BRCA1-Associated Protein-1 Is a Tumor Suppressor that Requires Deubiquitinating Activity and Nuclear LocalizationCancer Research, 2008
- Determinants of protein function revealed by combinatorial entropy optimizationGenome Biology, 2007
- Potential Role of Histone Deacetylase Inhibitors in Mesothelioma: Clinical Experience with Suberoylanilide Hydroxamic AcidClinical Lung Cancer, 2006
- High-resolution characterization of the pancreatic adenocarcinoma genomeProceedings of the National Academy of Sciences of the United States of America, 2004
- Metagenes and molecular pattern discovery using matrix factorizationProceedings of the National Academy of Sciences of the United States of America, 2004
- BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppressionOncogene, 1998